Maryland on Thursday charged Insys Therapeutics Inc with deceptively marketing a powerful opioid pain killer so that it was prescribed inappropriately beyond its intended use with cancer patients.
from Reuters: Health https://ift.tt/2NQG4NW
via
IFTTT
0 comments: